Conference Coverage

Consider spironolactone in treatment-resistant hypertension


 

REPORTING FROM ACC 18


Dr. Thompson noted that it’s not possible to look at prescription-filling rates in the PINNACLE registry.

“Unfortunately, we can’t exclude white coat hypertension or nonadherence as reasons why patients in PINNACLE end up on multiple antihypertensive medication classes. We can see that a prescription was written, but we have no way to know if it was actually filled or not,” she observed.

Also, since patients in cardiology clinics typically have multiple cardiovascular comorbidities, it’s quite possible that patients with TRH who are on a beta-blocker, for example, might not have received that drug for blood pressure control.

Dr. Thompson’s study was supported by the ACC’s National Cardiovascular Disease Registry. She reported having no financial conflicts of interest.

Source: Thompson L. ACC 18. Abstract 1324M-09.

Pages

Recommended Reading

Health disparities in rural America: Chronic conditions
MDedge Endocrinology
Bariatric surgery comes with some risk of complications
MDedge Endocrinology
Learn ‘four Ds’ approach to heart failure in diabetes
MDedge Endocrinology
Aspirin blunts early stroke risk from preeclampsia
MDedge Endocrinology
Can case management cut hypertension’s consequences?
MDedge Endocrinology
Hypertension guidelines unlikely to hold sway with PCPs
MDedge Endocrinology
Barbershop intervention cuts blood pressure in black men
MDedge Endocrinology
Major message: Most heart failure is preventable
MDedge Endocrinology
VIDEO: Triple-antihypertensive pill nails early therapy
MDedge Endocrinology
MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Endocrinology